日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dolutegravir/Abacavir/Lamivudine in Acute HIV-1 Results in Rapid Suppression and Restoration of CD4 T-cell Subsets Without Accelerated Decay of Latent HIV-1

多替拉韦/阿巴卡韦/拉米夫定治疗急性 HIV-1 感染可快速抑制和恢复 CD4 T 细胞亚群,且不会加速潜伏 HIV-1 的衰减。

Cynthia L Gay ,Jessica Keys ,JoAnn D Kuruc ,Alexis Sponaugle ,Kara S McGee ,Chelston Ang ,Caroline E Baker ,Eric T Weimer ,John L Schmitz ,Nancie M Archin ,Mehri S McKellar ,Nilu Goonetilleke ,David M Margolis ,Joseph J Eron

Dominant CD4+ T cell receptors remain stable throughout antiretroviral therapy-mediated immune restoration in people with HIV

在HIV感染者中,优势CD4+ T细胞受体在抗逆转录病毒疗法介导的免疫重建过程中保持稳定。

Alexis Sponaugle,Ann Marie K Weideman,Jolene Ranek,Gatphan Atassi,JoAnn Kuruc,Adaora A Adimora,Nancie M Archin,Cynthia Gay,Daniel R Kuritzkes,David M Margolis,Benjamin G Vincent,Natalie Stanley,Michael G Hudgens,Joseph J Eron,Nilu Goonetilleke